Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-05-16 14:52:02
Reporting Period:
Filing Date:
Accepted Time:
2017-05-16 14:52:02
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1226616 Medicinova Inc MNOV Pharmaceutical Preparations (2834) 330927979
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589259 Yutaka Kobayashi C/o Medicinova, Inc.
4275 Executive Square, Suite 650
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-15 1,000 $5.60 25,000 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 81,800 Direct
  1. The reported shares were purchased with Japanese Yen. The purchase price reported in Column 4 is reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent.